Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.09267 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.47296 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.15698 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.3854 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.29694 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.57552 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.00793 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.35563 | 85 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.45191 | 86 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.23911 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.08749 | 83 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.22139 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.35675 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.07139 | 83 |